Qingliang Yang - Hangzhou DAC Biotech Co Ltd

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 11 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract 5821: DXC008, a novel STEAP1 antibody-tubulysin analog conjugate with a function linker, demonstrates a potential to broaden therapeutic opportunities for prostate tumors

Qingliang Yang,Yuanyuan Huang,Junxiang Jia,Huihui Guo, Lingli Zhang,You Zhou,Zhicang Ye,Hangbo Ye,Yifang Xu, WenJun Li, Zhiyu Zhao, Lingyao Zhao, Lu Bai, Jun Zheng,Robert Y. Zhao

Cancer Researchno. 6_Supplement (2024): 5821-5821

引用0浏览0引用

Abstract 1883: A MUC1 Antibody-Conjugated with a Tubulysin B Analog, DXC005, Demonstrates Excellent Synergistic Effect in Combination with Gemcitabine for Treatment of Pancreatic Tumors

Xiaobo Cai, Min Cao,Huihui Guo,Qingliang Yang,Yongxiang Chen,Xiangfei Kong,Yong Du,Zhicang Ye,Zhixiang Guo,Lingli Zhang,Lu Bai,Junxiang Jia,Yunxia Zheng,Wei Zheng,Jun Zheng,Wenjun Li,Yuanyuan Huang,Zhongliang Fan,Binbin Chen, Yanlei Yang,Meng Dai,Robert Y. Zhao

Cancer Researchno. 6_Supplement (2024): 1883-1883

引用0浏览0引用

Abstract 4553: DXC004A, a novel EGFR antibody-tubulysin analog conjugate demonstrated potential to broaden therapeutic opportunities for non-small cell lung cancer

Cancer Researchno. 6_Supplement (2024): 4553-4553

引用0浏览0引用

Abstract 6581: DX126-262 combined with chemotherapy (Cisplatin and 5-Fu) demonstrates promising antitumor efficacy in HER2-positive gastric cancer

Cancer Researchno. 6_Supplement (2024): 6581-6581

引用0浏览0引用

Abstract 5820: an Antibody Drug Conjugate Platform Based on Novel Camptothecin Payloads with Branch Hydrophilic Linkers and Site-Specific Conjugation

Yuanyuan Huang,Hangbo Ye,Qingliang Yang, Lingli Zhang,Huihui Guo, Xiaolei Liu, Wenjun Li, Lu Bai,Junxiang Jia, Juan Wang,Xiangfei Kong, Jun Zheng,Yifang Xu, Gengxiang Zhao,Linyao Zhao, Xiang Cai, Ziyu Zhao, Hui Xia, Xia Zhou,You Zhou,Robert Y. Zhao

CANCER RESEARCHno. 6 (2024)

引用0浏览0引用

Abstract 5819: an Anti-Trop2-cpt113 ADC, Exhibits Potent Targeted Antitumor Activity and Favorable Pharmacokinetic Properties

Cancer Researchno. 6_Supplement (2024): 5819-5819

引用0浏览0引用

Abstract 1882: DXC024, a novel anti-TROP2/EGFR bispecific antibody and tubulysin conjugate, for targeted treatment of highly TROP2- or EGFR-expressing tumors

Cancer Researchno. 6_Supplement (2024): 1882-1882

引用0浏览0引用

Abstract 1884: DXC006, Anti-CD56-CPT113 ADC Displays Favorable Anti-Tumor Efficacy, Pharmacokinetic and Safety Profiles in Preclinical Studies

Cancer Researchno. 6_Supplement (2024): 1884-1884

引用0浏览0引用

Abstract 3147: DXC025, a Novel Anti-Muc1/egfr Bispecific Antibody-Tubulysin Conjugate with a Function Linker, Exhibits Potent Anti-Tumor Efficacy

Xingyan Jiang,Junxiang Jia,Huihui Guo,Xiangfei Kong, Yongfang Xu, Sishi Ye,Yong Du,Zhicang Ye, Qikuang Cen,Lingli Zhang,Yongxiang Chen, Gaituo Chen,Lu Bai,Yunxia Zheng,Wei Zheng,Jun Zheng,Juan Wang,Wenjun Li,Yuanyuan Huang,Linyao Zhao,Yifang Xu,Mengmeng Liu,Binbin Chen,Meng Dai,Miaomiao Chen,Zhixiang Guo,Qingliang Yang,Robert Y. Zhao

Cancer Researchno. 6_Supplement (2024): 3147-3147

引用0浏览0引用

Abstract 4532: Functional Evaluation of Novel Tubulysin Analogs As Payloads for Antibody-Drug Conjugates

Junxiang Jia,Xiaomai Zhou,Yuanyuan Huang,Hongsheng Xie,Huihui Guo,Shun Gai,Lan Qu,Wenjun Li, Lin Chen,Xing Li,Sanxing Sun,Qingliang Yang, Xiaotao Zhuo,Hangbo Ye,Robert Zhao

Cancer research（2015）

引用2浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn